1 - 8 of 8

Michael S. Marks, PhD

Michael S. Marks

Dr. Marks investigates the molecular mechanisms underlying the formation of cell type-specific lysosome-related organelles; the assembly, delivery and function of their contents; and how these processes are impacted by genetic diseases.


Eric D. Marsh, MD, PhD

Eric D. Marsh

Dr. Marsh's research program focuses on understanding how changes in brain development lead to epilepsy, intellectual disability, and autism. He combines molecular and physiological tools in mouse models to ask questions about the interaction of normal development with single gene mutations to determine how the brain responds to perturbations in development.


Shana E. McCormack, MD, MTR

Shana E. McCormack

Dr. McCormack investigates the intersection of neuroendocrinology and metabolism. Her translational research program involves two areas. The first involves studying those with genetic disorders, including primary mitochondrial diseases and Friedreich's ataxia, with characterized risk for diabetes mellitus. Second, Dr. McCormack focuses on brain disorders associated with excess weight gain, including brain tumor-related hypothalamic obesity syndrome and idiopathic intracranial hypertension.


Denise M. Melvin, MSM, RBP

Denise M. Melvin

Oversees three departments committed to the health and safety of Research Institute staff and serves as the Institutional Biosafety Officer.


Kevin E. C. Meyers, MBBCh

Kevin E. C. Meyers, MBBCh

Dr. Meyers' research addresses ways to help improve outcomes in children with nephrotic syndrome and hypertension.


Dimitrios S. Monos, PhD

Dimitrios S. Monos

Dr. Monos is an internationally recognized expert on histocompatibility (HLA) molecules. His work covers a wide spectrum of HLA-related issues that pertain to both the molecular (structure/function) aspects of HLAs, as well as the genetics of the major histocompatibility complex, that includes the genes encoding the HLA molecules.


Amanda B. Muir, MD

Amanda B. Muir

Dr. Muir investigates the mechanisms underlying esophageal fibrosis to improve therapeutic and diagnostic approaches.